ExcelMab
Guangzhou
About ExcelMab
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2020)
- Website: excelmab.com
- Phone: 020-28211020
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/excelmab-124144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.